Načítá se...
Eukaryotic Phosphatase Inhibitors Enhance Colistin Efficacy in Gram-negative Bacteria.
The mounting threat of multi-drug resistant (MDR) bacteria places a tremendous strain on the antimicrobial clinical arsenal, forcing physicians to revert to near-obsolete antibiotics to treat otherwise intractable infections. Antibiotic adjuvant therapy has emerged as a viable alternative to the dev...
Uloženo v:
| Vydáno v: | Chem Biol Drug Des |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7704794/ https://ncbi.nlm.nih.gov/pubmed/32562384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cbdd.13735 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|